Journal News

From the journals: MCP

Laura Elyse McCormick
Sept. 9, 2022

Understanding the stages of mitophagy. Defining subcellular localization. Read about papers on these topics recently published in the journal Molecular & Cellular Proteomics.

 

Working from the outside in

As cells adjust to the stresses of life, mitochondria also must adapt. Over time, mitochondria get damaged and then recycled by a specialized autophagy process called mitophagy.

Shown over time from left to right, mitochondria are broken down from the outside in during mitophagy.
Zittlau et al.
Shown over time from left to right, mitochondria are broken down from the outside
in during mitophagy.

During mitophagy, proteins are marked for degradation through ubiquitination. Phosphorylation works in tandem with ubiquitination, as each modification can provide positive or negative feedback for the other. In particular, mitophagy requires the E3 ubiquitin ligase parkin and the serine/threonine-protein kinase PINK1. Researchers have identified mutations in both enzymes in Parkinson’s disease, so understanding their function is critical.

Despite an abundance of literature, scientists still have key questions about the process of mitophagy. Some researchers have demonstrated that autophagosomes consume mitochondria all at once during mitophagy, although others suggest individual sections within the mitochondria can be broken down piece by piece.

In a recent paper published in the journal Molecular & Cellular Proteomics, Katharina I. Zittlau and colleagues at the University of Tübingen describe using a three-tiered proteomic approach to examine parkin-dependent mitophagy in HeLa cells. After inducing mitophagy, the team quantified total protein levels over 18 hours to evaluate mitochondrial protein degradation in the presence or absence of functional parkin. They also measured changes in protein ubiquitination and phosphorylation.

Their data support an outside–in breakdown of mitochondria during mitophagy, showing evidence for the ubiquitination and degradation of proteins in the outer mitochondrial compartments first, with the inner compartments following later. Using a vast data set, the researchers also identified examples in which a phosphorylation event blocked or enhanced ubiquitination during mitophagy. In particular, they showed that dephosphorylation of voltage-dependent anion-selective channel protein 2 is required for its parkin-dependent ubiquitination and ultimate degradation.

This study provides detailed information that enhances our knowledge of mitophagy as well as the specific contribution of parkin to each stage of the process.

Mapping the cell

The cytoplasm is a densely packed yet well-organized space. A multitude of biochemical reactions occur simultaneously, each localized to a specific domain, such as inside the nucleus, on the mitochondrial surface or at the plasma membrane. As a result, the localization of RNA and proteins — as well as the intracellular trafficking to their final destination — must be tightly regulated. Disruption of this spatial organization can be problematic, as numerous diseases are characterized by mislocalized proteins.

Although researchers can gain a wealth of knowledge from global transcriptomic and proteomic data sets, the story is incomplete without spatial information. Local enrichment or depletion of macromolecules — often masked in whole-cell omics — regulates these biological pathways and, ultimately, cell function.

Josie A. Christopher and a team from the University of Cambridge recently published a comprehensive review of methods used to study the subcellular localization of proteins and RNA in the journal Molecular & Cellular Proteomics. The authors provide a detailed overview of techniques such as microscopy-based assays, imaging mass cytometry, and coupling proteomics/transcriptomics with biochemical fractionations or proximity labeling. The advantages and limitations of each are discussed to help readers select the best methods for their own projects.

The techniques highlighted in this review will be crucial in answering basic questions about cellular organization as well as leading the way for translational research and new diagnostic approaches.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laura Elyse McCormick

Laura McCormick is a graduate student in the Department of Cell Biology and Physiology at the University of North Carolina at Chapel Hill.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.